Therapeutical Dose to Thyroid Remnants Determination for Low-risk Thyroid Carcinoma Patient Treated with rhTSH and 1.1 GBq 131I

被引：0
|
作者：
Solny, P. [1 ,2 ,3 ]
Kracmerova, T. [1 ,2 ,3 ]
Jonasova, L. [2 ,3 ]
Vlcek, P. [2 ,3 ]
机构：
[1] Czech Tech Univ, Dept Dosimetry & Applicat Ionizing Radiat, Fac Nucl Sci & Phys Engn, Prague, Czech Republic
[2] Charles Univ Prague, Dept Nucl Med & Endocrinol, Fac Med 2, Prague, Czech Republic
[3] Motol Univ Hosp, Prague, Czech Republic
来源：
RADIOTHERAPY AND ONCOLOGY | 2016年 / 118卷
关键词：
dosimetry; iodine therapy; 1.1; GBq;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
199
引用
收藏
页码：S97 / S97
页数：1
相关论文
共 50 条
  • [21] Estimation of effective dose at thyroid cancer patients treated with 131I
    Kochovska, M. Zdraveska
    Majstorov, V.
    Jokic, V. Spasic
    Bogdanovska, A.
    Ristevska, N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S502 - S502
  • [22] Randomised comparison of 1.1 GBq and 3.7 GBq radioiodine to ablate the thyroid in the treatment of low-risk thyroid cancer: a 13-year follow-up
    Ahtiainen, Veera
    Vaalavirta, Leila
    Tenhunen, Mikko
    Joensuu, Heikki
    Maenpaa, Hanna
    ACTA ONCOLOGICA, 2020, 59 (09) : 1064 - 1071
  • [23] Is radioiodine ablation with 1.1 GBq (30 mCi) 131I necessary in low-risk thyroid cancer patients? Results from a long-term follow-up prospective study
    Verónica Ilera
    Inés Califano
    Andrea Cavallo
    Eduardo Faure
    Adriana Vázquez
    Fabián Pitoia
    Endocrine, 2023, 80 : 606 - 611
  • [24] Thyroid Ablation with 1.1GBq (30 mCi) Iodine-131 in Patients with Papillary Thyroid Carcinoma at Intermediate Risk for Recurrence
    Rosario, Pedro Weslley
    Calsolari, Maria Regina
    THYROID, 2014, 24 (05) : 826 - 831
  • [25] 131I Radiation Dose Distribution in Metastases of Thyroid Carcinoma REPLY
    Champion, Christophe
    Zanotti-Fregonara, Paolo
    Hindie, Elif
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (05) : 834 - 834
  • [26] The risk of second primary malignancy is increased in differentiated thyroid cancer patients with a cumulative 131I dose over 37 GBq
    Khang, Ah Reum
    Cho, Sun Wook
    Choi, Hoon Sung
    Ahn, Hwa Young
    Yoo, Won Sang
    Kim, Kyung Won
    Kang, Keon Wook
    Yi, Ka Hee
    Park, Do Joon
    Lee, Dong Soon
    Chung, June-Key
    Cho, Bo Youn
    Park, Young Joo
    CLINICAL ENDOCRINOLOGY, 2015, 83 (01) : 117 - 123
  • [27] Implementation of a card with instructions for patients treated for thyroid carcinoma with 131I
    Minguez, Pablo
    Genolla, Jose
    Cruz Fombellida, Jose
    RADIATION PROTECTION DOSIMETRY, 2012, 151 (01) : 76 - 80
  • [28] Dosimetry of 131I in remnant ablation and metastasis of differentiated thyroid cancer treated with high radioactivities and rhTSH
    Ramirez-Franco, Jorge
    Torres-Garcia, Eugenio
    Flores-Reyes, Mario
    Torres-Garcia, Gustavo
    Perez-Soto, Elvia
    RADIATION EFFECTS AND DEFECTS IN SOLIDS, 2024, 179 (9-10): : 1284 - 1294
  • [29] 131I thyroid uptake in patients treated with 131I-Lipiodol for hepatocellular carcinoma
    Toubeau, M
    Touzery, C
    Berriolo-Riedinger, A
    Cochet, A
    Brunotte, F
    Bedenne, L
    Cercueil, JP
    Krause, D
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (05) : 669 - 670
  • [30] Required therapeutic dose of 131I for thyroid ablation after surgery for differentiated thyroid carcinoma
    Yaneva, M.
    Botushanova, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S399 - S399
12345